Medicine and Life Sciences - Pharmacology
An international team has shown that the injection of a type of stem cell into the brains of patients living with progressive multiple sclerosis (MS) is safe, well tolerated and has a long-lasting effect that appears to protect the brain from further damage. I am cautiously very excited about our findings, which are a step towards developing a cell therapy for treating MS Stefano Pluchino The study, led by scientists at the University of Cambridge, University of Milan Bicocca and Hospital Casa Sollievo della Sofferenza (Italy), is a step towards developing an advanced cell therapy treatment for progressive MS.
Dermatologist Prof. Jörg Wenzel of Bonn University Hospital and University of Bonn has collaborated with Incyte, a U.S.-based global biopharmaceutical company, to develop a strategy for treating patients with severe pruritus (prurigo nodularis) with ruxolitinib cream. The University of Bonn and Incyte have now entered into an agreement whereby Incyte has acquired the rights to a related joint patent application from Bonn.
A study by University of Calgary researchers and the Canadian Immunization Research Network may prompt a change to vaccination guidelines for infants.
City of Kitchener's Carl Zehr Square lights up for World Antimicrobial Awareness Week By Milana Madzarac School of Pharmacy Antimicrobial resistance (AMR) is a top global threat to both human health and food security - with significant negative economic impacts - yet most people are unaware of the harm it is causing to society.
Minimally invasive focal therapies for prostate cancer are associated with a lower overall cost and improved quality of life for patients.
News from Collaborative Research Centre (CRC) 1423, "Structural Dynamics of GPCR Activation and Signal Transduction", led by biochemists Professor Annette Beck-Sickinger and Professor Torsten Schöneberg from Leipzig University, has been extended for a second funding period.
A new AI model developed by chemists at ETH Zurich can not only predict where a pharmaceutically active molecule can be chemically modified, but also how best to do it. This makes it possible to identify new pharmaceutical ingredients more quickly and improve existing ones in a targeted manner.
Ketul Patel receives Mitacs Award for Outstanding Innovation-Postdoctoral for his work developing a first-of-its-kind, non-addictive medication to treat chronic pain A UCalgary researcher is part of a team developing revolutionary medication that could have a significant impact on millions of people who suffer from chronic pain.
COVID-19 caused an alarming surge in premature births, but vaccines were key to returning the early birth rate to pre-pandemic levels, according to a new analysis of California birth records.
Setting a new standard in clinical cancer research - that is the goal of Bavarian researchers within the WERA alliance. As of today, the alliance is part of the National Centre for Tumour Diseases (NCT).
Cancer biologists at EPFL, UNIGE, and the German Cancer Research Center (Heidelberg) have developed a novel immunotherapy that does not require knowledge of a tumor's antigenic makeup. The new results may pave the way to first-in-kind clinical applications.
The most socioeconomically deprived groups in society are nearly twice as likely to die from sepsis within 30 days, researchers from The University of Manchester have found. The study of NHS data analysed 248,767 cases of non-COVID-19 sepsis from January 2019, to June, 2022 matched with 1,346,166 controls.
Two Radboud researchers are set to receive a Consolidator Grant from the European Research Council (ERC). Lisa Genzel, a neurobiologist at the Donders Institute, will research how we build-up and update knowledge networks in our brain. Kim Bonger, of the Institute for Molecules and Materials, will study CAR T cell therapy as a method of cancer treatment.
Physiotherapeut:in/ Ergotherapeut:in (m/w/x, 50%) Technische Universität München
Postdoctoral Research Scientist-Clinical Pharmacology and Toxicology Laboratory Columbia University
Pharmaceutical Engineer (m/f/d) Technische Universität Wien
Researcher in Health Economics University of Oxford
Research Associate (fixed-term) University of Bath
Lecturer (fixed-term) University of Bath
Postdoctoral Researcher in dementia and kidney disease, Clinical geriatrics Karolinska Institute, Stockholm
Research Fellow Queen’s University Belfast
Assistant Professor - Nuclear Pharmacist Columbia University
Research Project Coordinator, Family Medicine University of Calgary
Director, Regional and Pipeline Development University of California Riverside
Clinical Research Assistant, Psychiatry University of Calgary
Assistant Professor-Biomolecular Science University of Toronto
Tenure Stream Faculty Position - Pharmacokinetics Dalhousie University
Research assistant to Karolinska Institutet Karolinska Institute, Stockholm
Research Support Specialist University of Oxford
Links - Pharmacology
New therapeutic approach for prurigo nodularis
High-performance Oncological Medicine Made in Germany
Studying the healing power of psychedelics
On the spot when life begins too early
University of Glasgow spin-out Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria
Mattias Mandorfer honoured with the United European Gastroenterology Rising Star Award
Better use of existing drugs increases cervical cancer survival and reduces recurrence
The Centre for Drug Design and Discovery raises 70.5 Million Euros for its fourth fund
GPs could improve access to ADHD treatment
Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases
Researchers advancing health across the state
David Cameron visits new centre of excellence for UCL Neuroscience to mark World Alzheimer's Day
Broken String Biosciences closes $15m funding round
UBC experts on approval of updated COVID-19 vaccine
Research team secures £2.25 million to help improve immunotherapy treatments for cancer
How the Immune System Keeps Gut Bacteria under Control
Many older adults want RSV vaccine, but levels of awareness, interest vary by age, health
Grant recipients addressing critical gaps in health care